NCT07339488
- Conditions
- Borderline Resectable Carcinoma, Carcinoma, Carcinoma, Squamous Cell, +19 more
- Locations
-
- Cancer Hospital, Shantou University Medical College Shantou, Guangdong, China
Clinical trial condition
Explore clinical trials studying Tislelizumab. Study availability and eligibility vary by location and protocol.
NCT07339488
NCT07089199
NCT07136077
NCT07458529
NCT07233252
NCT07198217
NCT07125547
NCT07086456
NCT07085182
NCT05920863